CALCIUM GLUCONATE

CALCIUM GLUCONATE was reported 12182 times

CALCIUM GLUCONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ISCHAEMIC CONTRACTURE OF THE LEFT VENTRICLE 12 0.5000
1 LUPUS VULGARIS 313 0.2484
2 SLEEP DISORDER THERAPY 49 0.2475
3 ANTACID THERAPY 32 0.2462
4 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 132 0.2353
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 147 0.2201
6 GRIP STRENGTH 47 0.2052
7 SWOLLEN JOINT COUNT INCREASED 604 0.1892
8 APPENDICOLITH 73 0.1886
9 HEPATIC ENZYME 28 0.1879
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 361 0.1802
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 368 0.1774
12 DISLOCATION OF VERTEBRA 384 0.1682
13 ANALGESIC THERAPY 53 0.1651
14 POLYGLANDULAR DISORDER 11 0.1618
15 RHEUMATIC FEVER 719 0.1611
16 X-RAY ABNORMAL 269 0.1503
17 CENTRAL NERVOUS SYSTEM MASS 14 0.1474
18 DRUG THERAPY 49 0.1445
19 C-REACTIVE PROTEIN 133 0.1435
20 VAGINAL FLATULENCE 43 0.1419
21 RHEUMATOID FACTOR POSITIVE 789 0.1365
22 WALL MOTION SCORE INDEX ABNORMAL 15 0.1364
23 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 866 0.1207
24 MUSCULOSKELETAL DEFORMITY 28 0.1197
25 AIRWAY REMODELLING 14 0.1129
26 RETINITIS 190 0.1099
27 ANTICOAGULANT THERAPY 31 0.1092
28 SWOLLEN JOINT COUNT 27 0.1080
29 PEMPHIGUS 1301 0.1040
30 DUODENAL ULCER PERFORATION 762 0.1024
31 RED BLOOD CELL SEDIMENTATION RATE 28 0.1004
32 FACET JOINT SYNDROME 324 0.0994
33 JOINT DESTRUCTION 144 0.0925
34 MALIGNANT MELANOMA STAGE 0 19 0.0909
35 CONGENITAL HIATUS HERNIA 19 0.0833
36 PERIPHERAL VENOUS DISEASE 339 0.0829
37 BURKHOLDERIA TEST POSITIVE 10 0.0806
38 HAND DEFORMITY 1027 0.0782
39 PORPHYRIA ACUTE 112 0.0780
40 MUSCLE INJURY 636 0.0767
41 BACTEROIDES INFECTION 20 0.0766
42 HELICOBACTER INFECTION 763 0.0742
43 SERONEGATIVE ARTHRITIS 83 0.0724
44 HYPOCHOLESTEROLAEMIA 25 0.0708
45 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 439 0.0675
46 ANTIPHOSPHOLIPID ANTIBODIES 13 0.0667
47 HYPERDYNAMIC LEFT VENTRICLE 16 0.0650
48 MULTIPLE DRUG THERAPY 48 0.0637
49 GASTROINTESTINAL PROCEDURAL COMPLICATION 17 0.0634
50 ANAEMIA FOLATE DEFICIENCY 12 0.0622
51 GENITAL EROSION 18 0.0606
52 ANKLE ARTHROPLASTY 22 0.0606
53 BONE EROSION 209 0.0590
54 OVERLAP SYNDROME 41 0.0586
55 BLOOD IMMUNOGLOBULIN A DECREASED 38 0.0584
56 DRUG TOLERANCE DECREASED 164 0.0583
57 FOLLICULITIS 590 0.0562
58 PERICARDITIS 923 0.0549
59 GLOSSODYNIA 1227 0.0547
60 SYNOVITIS 932 0.0516
61 ATOPY 14 0.0504
62 C-REACTIVE PROTEIN ABNORMAL 317 0.0494
63 BLOOD IMMUNOGLOBULIN M INCREASED 30 0.0493
64 DEATH NEONATAL 67 0.0481
65 BREAST CANCER STAGE III 310 0.0478
66 LIVER INJURY 1167 0.0475
67 WOUND INFECTION 482 0.0440
68 LIP DRY 395 0.0434
69 HYPERCHOLESTEROLAEMIA 415 0.0429
70 GRIP STRENGTH DECREASED 362 0.0411
71 ELECTROCARDIOGRAM P WAVE ABNORMAL 10 0.0408
72 HYPERPHOSPHATAEMIA 84 0.0390
73 PUSTULAR PSORIASIS 132 0.0384
74 JOINT RANGE OF MOTION DECREASED 512 0.0381
75 CSF PRESSURE INCREASED 10 0.0376
76 BLEPHAROSPASM 234 0.0371
77 AUTOIMMUNE DISORDER 357 0.0366
78 SYSTEMIC LUPUS ERYTHEMATOSUS 1275 0.0359
79 VASCULAR ACCESS COMPLICATION 29 0.0358
80 WOUND 939 0.0336
81 FIBROMYALGIA 814 0.0334
82 MEAN PLATELET VOLUME DECREASED 28 0.0334
83 LIVE BIRTH 276 0.0330
84 CONTRAINDICATED PRODUCT ADMINISTERED 974 0.0321
85 NEONATAL INFECTION 11 0.0318
86 PSORIATIC ARTHROPATHY 1283 0.0316
87 INFUSION SITE REACTION 94 0.0314
88 IRRITABLE BOWEL SYNDROME 663 0.0309
89 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 71 0.0308
90 BLOOD PHOSPHORUS INCREASED 82 0.0300
91 CHEST WALL PAIN 10 0.0299
92 BURSITIS 360 0.0296
93 PRESCRIBED OVERDOSE 572 0.0295
94 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 10 0.0292
95 PULMONARY FIBROSIS 540 0.0281
96 RASH VESICULAR 135 0.0279
97 ULCER HAEMORRHAGE 187 0.0276
98 HYPOPARATHYROIDISM 21 0.0274
99 BREAST CANCER STAGE II 223 0.0268
100 FEMALE GENITAL TRACT FISTULA 45 0.0263
101 BLOOD IMMUNOGLOBULIN G INCREASED 32 0.0263
102 EYE INJURY 79 0.0260
103 DRUG TOLERANCE 130 0.0257
104 WALKING AID USER 168 0.0255
105 SCIATICA 401 0.0251
106 OBESITY 383 0.0240
107 LOWER LIMB FRACTURE 458 0.0238
108 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 22 0.0237
109 TYPE 2 DIABETES MELLITUS 784 0.0233
110 ARTHROPATHY 1290 0.0232
111 TOTAL LUNG CAPACITY DECREASED 36 0.0225
112 HIP ARTHROPLASTY 334 0.0218
113 MATERNAL EXPOSURE TIMING UNSPECIFIED 81 0.0215
114 EXOSTOSIS 196 0.0214
115 POLYARTHRITIS 113 0.0214
116 FOOT DEFORMITY 237 0.0214
117 RED BLOOD CELL SEDIMENTATION RATE INCREASED 236 0.0213
118 CARDIAC SEPTAL DEFECT 15 0.0209
119 RED BLOOD CELLS URINE POSITIVE 20 0.0207
120 SCROTAL PAIN 11 0.0204
121 DYSPNOEA EXACERBATED 10 0.0194
122 LUPUS-LIKE SYNDROME 175 0.0193
123 PRESCRIBED UNDERDOSE 383 0.0192
124 EOSINOPHILIC MYOCARDITIS 14 0.0192
125 CHRONIC SINUSITIS 69 0.0184
126 IMPAIRED HEALING 599 0.0182
127 MEAN CELL VOLUME DECREASED 28 0.0181
128 BLOOD CHOLESTEROL INCREASED 843 0.0181
129 TERMINAL ILEITIS 11 0.0179
130 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 306 0.0178
131 RADICULOPATHY 46 0.0174
132 BRASH SYNDROME 24 0.0171
133 MICROANGIOPATHY 16 0.0170
134 MEAN CELL HAEMOGLOBIN DECREASED 31 0.0169
135 DELAYED GRAFT FUNCTION 12 0.0169
136 HYPERMAGNESAEMIA 11 0.0168
137 CULTURE POSITIVE 14 0.0167
138 CARDIOVASCULAR INSUFFICIENCY 27 0.0166
139 ENDOMETRITIS 11 0.0165
140 GENERAL SYMPTOM 124 0.0165
141 HYPOPHOSPHATAEMIA 122 0.0165
142 CHRONIC HEPATITIS 13 0.0160
143 ONYCHOMADESIS 67 0.0159
144 NECROTISING COLITIS 20 0.0158
145 NAIL DISORDER 138 0.0158
146 KNEE ARTHROPLASTY 332 0.0158
147 RHEUMATIC DISORDER 30 0.0155
148 NASAL OEDEMA 28 0.0155
149 MUCOSAL EROSION 14 0.0154
150 INCISION SITE PAIN 18 0.0153
151 MYOSITIS 137 0.0153
152 JOINT DISLOCATION 160 0.0151
153 DIFFICULTY IN WALKING 52 0.0151
154 RECALLED PRODUCT 26 0.0150
155 LOWER RESPIRATORY TRACT INFECTION 682 0.0150
156 PROCTITIS 42 0.0150
157 GAIT INABILITY 498 0.0149
158 NAIL INFECTION 21 0.0146
159 OEDEMA 787 0.0145
160 HYPOCALCAEMIA 271 0.0143
161 THERAPEUTIC PRODUCT EFFECT DECREASED 639 0.0143
162 DISCOMFORT 870 0.0142
163 INFUSION RELATED REACTION 930 0.0140
164 BLOOD URIC ACID INCREASED 78 0.0135
165 BLISTER 752 0.0134
166 IRON DEFICIENCY 59 0.0131
167 RHEUMATOID ARTHRITIS 1435 0.0126
168 TOXIC EPIDERMAL NECROLYSIS 190 0.0125
169 WHEEZING 737 0.0124
170 MOBILITY DECREASED 880 0.0122
171 DELIRIUM 424 0.0122
172 STOMATITIS 733 0.0121
173 MACULAR DEGENERATION 143 0.0120
174 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 60 0.0118
175 HEPATIC ENZYME INCREASED 805 0.0118
176 BLOOD CALCIUM INCREASED 103 0.0117
177 SWELLING 1089 0.0116
178 OSTEOARTHRITIS 490 0.0115
179 AORTIC STENOSIS 40 0.0115
180 NIGHT SWEATS 367 0.0114
181 LUNG OPACITY 30 0.0114
182 SPONDYLITIS 41 0.0113
183 SHOULDER PAIN 11 0.0112
184 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 14 0.0112
185 HEPATIC CIRRHOSIS 208 0.0111
186 MATERNAL EXPOSURE DURING PREGNANCY 985 0.0110
187 DISTRIBUTIVE SHOCK 25 0.0110
188 TASTE DISORDER 223 0.0110
189 EXERCISE TOLERANCE DECREASED 63 0.0109
190 COLOUR BLINDNESS 10 0.0109
191 ADRENAL INSUFFICIENCY 130 0.0107
192 MYASTHENIA GRAVIS 86 0.0106
193 C-REACTIVE PROTEIN INCREASED 386 0.0106
194 DRUG INTOLERANCE 1021 0.0106
195 RESPIRATORY SYMPTOM 30 0.0105
196 INJURY 711 0.0101
197 VENTRICULAR FIBRILLATION 112 0.0101
198 IMMUNODEFICIENCY 148 0.0099
199 DISABILITY 195 0.0099
200 SPINAL FUSION SURGERY 40 0.0098
201 BLOOD PRESSURE INADEQUATELY CONTROLLED 59 0.0098
202 ROAD TRAFFIC ACCIDENT 410 0.0098
203 BACK DISORDER 158 0.0097
204 CARDIOGENIC SHOCK 139 0.0097
205 BLOOD FIBRINOGEN DECREASED 11 0.0096
206 THERAPY NON-RESPONDER 432 0.0096
207 OBSTRUCTION 38 0.0095
208 COLITIS MICROSCOPIC 45 0.0095
209 ISCHAEMIC HEPATITIS 13 0.0095
210 METABOLIC ALKALOSIS 15 0.0093
211 LIVER DISORDER 402 0.0091
212 MONOCYTE COUNT INCREASED 32 0.0088
213 MUSCULOSKELETAL STIFFNESS 771 0.0088
214 HYPERTRANSAMINASAEMIA 61 0.0088
215 SLEEP DISORDER 616 0.0087
216 ENDOCRINE DISORDER 11 0.0086
217 ASPARTATE AMINOTRANSFERASE ABNORMAL 13 0.0085
218 APPENDICITIS 79 0.0084
219 ORAL INTAKE REDUCED 20 0.0083
220 HYPOTHALAMO-PITUITARY DISORDER 12 0.0082
221 TETANY 15 0.0082
222 TREATMENT FAILURE 680 0.0082
223 EPILEPSY 250 0.0082
224 CONGENITAL ANOMALY 63 0.0081
225 LUNG DISORDER 396 0.0081
226 INTENTIONAL PRODUCT USE ISSUE 704 0.0080
227 GENERAL PHYSICAL HEALTH DETERIORATION 929 0.0080
228 ILL-DEFINED DISORDER 487 0.0080
229 OPTIC ATROPHY 13 0.0080
230 PLEURITIC PAIN 22 0.0080
231 HYPERCALCAEMIA 97 0.0078
232 JOINT SWELLING 934 0.0077
233 BACK INJURY 84 0.0077
234 ENTHESOPATHY 12 0.0077
235 MUSCULOSKELETAL PAIN 402 0.0077
236 ABDOMINAL DISCOMFORT 1284 0.0076
237 VISUAL DISTURBANCE 43 0.0075
238 PREGNANCY 150 0.0075
239 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 15 0.0073
240 INFLAMMATION 378 0.0073
241 AMNESIA 476 0.0073
242 HYPOKALAEMIA 337 0.0073
243 BLOOD PRESSURE SYSTOLIC ABNORMAL 18 0.0073
244 PHARYNGOLARYNGEAL PAIN 38 0.0071
245 BLOOD PRESSURE DIASTOLIC ABNORMAL 18 0.0071
246 NEUROPATHY 12 0.0071
247 ONYCHOMYCOSIS 31 0.0071
248 HYPERNATRAEMIA 35 0.0070
249 ALOPECIA 1369 0.0070
250 STOMACH DISCOMFORT 36 0.0070
251 NEONATAL DISORDER 11 0.0069
252 NODULE 90 0.0069
253 EXPOSURE DURING PREGNANCY 428 0.0069
254 MULTIPLE ORGAN DYSFUNCTION SYNDROME 195 0.0069
255 JOINT STIFFNESS 180 0.0069
256 BILIRUBIN CONJUGATED INCREASED 16 0.0068
257 HISTOPLASMOSIS 12 0.0068
258 PANCREATITIS CHRONIC 16 0.0068
259 JOINT ARTHROPLASTY 12 0.0067
260 STAPHYLOCOCCAL SEPSIS 33 0.0067
261 COLONIC POLYP 11 0.0067
262 CONTUSION 637 0.0066
263 HEPATIC ENZYME ABNORMAL 33 0.0066
264 EAR INFECTION 175 0.0066
265 TROPONIN INCREASED 50 0.0066
266 FREQUENT BOWEL MOVEMENTS 177 0.0065
267 VENTRICULAR HYPOKINESIA 21 0.0065
268 DYSLIPIDAEMIA 33 0.0065
269 MATERNAL EXPOSURE BEFORE PREGNANCY 44 0.0064
270 VAGINAL DISCHARGE 65 0.0064
271 PUPIL FIXED 11 0.0063
272 HYPOPROTEINAEMIA 12 0.0063
273 BLOOD IMMUNOGLOBULIN E INCREASED 15 0.0062
274 SINUSITIS 634 0.0062
275 HYPOALBUMINAEMIA 48 0.0062
276 DRUG-INDUCED LIVER INJURY 193 0.0061
277 NORMAL NEWBORN 33 0.0061
278 HYPOAESTHESIA 902 0.0060
279 PROTEIN TOTAL INCREASED 16 0.0060
280 KLEBSIELLA INFECTION 30 0.0059
281 LIVER FUNCTION TEST INCREASED 127 0.0059
282 BREATH SOUNDS ABNORMAL 29 0.0059
283 EOSINOPHIL COUNT DECREASED 14 0.0059
284 PRODUCT LABEL CONFUSION 34 0.0058
285 SACROILIITIS 11 0.0058
286 CALCINOSIS 13 0.0058
287 PHYSICAL DISABILITY 25 0.0056
288 POOR PERIPHERAL CIRCULATION 24 0.0056
289 INTRAVENTRICULAR HAEMORRHAGE 14 0.0056
290 PHARMACEUTICAL PRODUCT COMPLAINT 146 0.0056
291 PRODUCT USE ISSUE 1053 0.0056
292 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 95 0.0056
293 DYSPEPSIA 550 0.0056
294 GASTROINTESTINAL DISORDER 500 0.0056
295 DRY MOUTH 446 0.0055
296 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 12 0.0055
297 ELECTROCARDIOGRAM T WAVE INVERSION 12 0.0054
298 EAR PAIN 105 0.0054
299 OSTEOPOROSIS 221 0.0054
300 BACTERIAL INFECTION 100 0.0054
301 SEPTIC SHOCK 233 0.0053
302 ASTHMA 604 0.0053
303 PARAESTHESIA ORAL 77 0.0053
304 LYMPHOCYTE COUNT DECREASED 94 0.0053
305 HYPERLIPIDAEMIA 63 0.0053
306 PULSELESS ELECTRICAL ACTIVITY 22 0.0053
307 BLOOD IMMUNOGLOBULIN G DECREASED 13 0.0052
308 ACIDOSIS 40 0.0052
309 HYPERTENSION 1106 0.0052
310 KIDNEY TRANSPLANT REJECTION 25 0.0052
311 MIGRAINE 497 0.0052
312 INFECTION 752 0.0052
313 METHAEMOGLOBINAEMIA 12 0.0052
314 VITILIGO 12 0.0051
315 SKIN REACTION 72 0.0051
316 JOINT EFFUSION 35 0.0051
317 COLITIS ISCHAEMIC 34 0.0050
318 PROTEIN URINE PRESENT 25 0.0050
319 RESPIRATORY DISORDER 150 0.0050
320 BLOOD CULTURE POSITIVE 15 0.0050
321 HAEMODYNAMIC INSTABILITY 38 0.0050
322 CANDIDIASIS 20 0.0050
323 DEVICE RELATED SEPSIS 10 0.0050
324 HYPERKALAEMIA 174 0.0050
325 RENAL TUBULAR NECROSIS 48 0.0049
326 SUSPECTED OFF LABEL USE 22 0.0049
327 RECTAL HAEMORRHAGE 209 0.0049
328 FOOT OPERATION 24 0.0048
329 BENIGN PROSTATIC HYPERPLASIA 25 0.0048
330 PERIPHERAL SWELLING 743 0.0048
331 CONFUSIONAL STATE 776 0.0048
332 MEDICATION ERROR 261 0.0047
333 OLIGURIA 29 0.0047
334 BLOOD ALBUMIN DECREASED 37 0.0047
335 TUMOUR LYSIS SYNDROME 41 0.0047
336 ORAL CANDIDIASIS 61 0.0046
337 WHITE BLOOD CELL COUNT INCREASED 177 0.0046
338 ARTHRITIS 359 0.0046
339 WHEELCHAIR USER 20 0.0045
340 NEURALGIA 109 0.0045
341 EMBOLISM 37 0.0045
342 EOSINOPHILIC PNEUMONIA 14 0.0044
343 COLITIS ULCERATIVE 198 0.0044
344 NASOPHARYNGITIS 815 0.0044
345 OEDEMA PERIPHERAL 538 0.0044
346 NEUTROPHIL COUNT INCREASED 45 0.0044
347 HYPERPARATHYROIDISM SECONDARY 11 0.0044
348 CATARACT OPERATION 26 0.0044
349 GASTROENTERITIS VIRAL 79 0.0044
350 HYPERSENSITIVITY 808 0.0043
351 BLOOD TEST ABNORMAL 61 0.0043
352 MULTIPLE ALLERGIES 34 0.0043
353 URTICARIA 725 0.0043
354 RESPIRATORY ACIDOSIS 17 0.0043
355 COVID-19 PNEUMONIA 51 0.0043
356 BRONCHIECTASIS 29 0.0043
357 BLOOD CALCIUM DECREASED 48 0.0043
358 HYPERVOLAEMIA 21 0.0042
359 END STAGE RENAL DISEASE 77 0.0042
360 COMPARTMENT SYNDROME 11 0.0042
361 NEUTROPENIC SEPSIS 30 0.0042
362 BLOOD UREA INCREASED 70 0.0042
363 DIABETES MELLITUS INADEQUATE CONTROL 74 0.0042
364 CHEST PAIN 774 0.0042
365 HYPOMAGNESAEMIA 58 0.0042
366 ACUTE RESPIRATORY FAILURE 80 0.0042
367 MEMORY IMPAIRMENT 571 0.0042
368 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
369 HYPERURICAEMIA 17 0.0041
370 ISCHAEMIA 19 0.0041
371 ASCITES 121 0.0041
372 FLUID RETENTION 208 0.0041
373 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 24 0.0040
374 ATELECTASIS 39 0.0040
375 ABDOMINAL TENDERNESS 20 0.0040
376 ASPIRATION 44 0.0040
377 CONDITION AGGRAVATED 1219 0.0040
378 BACTERIAL SEPSIS 13 0.0040
379 ENTEROCOLITIS 23 0.0040
380 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 191 0.0040
381 THERAPEUTIC RESPONSE DECREASED 239 0.0039
382 TONGUE OEDEMA 15 0.0039
383 STAPHYLOCOCCAL BACTERAEMIA 17 0.0039
384 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
385 BLOOD CHLORIDE DECREASED 10 0.0039
386 TRANSPLANT REJECTION 31 0.0039
387 FOETAL DEATH 20 0.0039
388 HEPARIN-INDUCED THROMBOCYTOPENIA 19 0.0039
389 INJECTION SITE IRRITATION 49 0.0038
390 PLEURAL EFFUSION 234 0.0038
391 CYTOKINE RELEASE SYNDROME 77 0.0038
392 SINUS BRADYCARDIA 37 0.0038
393 HYPOXIA 134 0.0038
394 ELECTROLYTE IMBALANCE 44 0.0038
395 FUNCTIONAL GASTROINTESTINAL DISORDER 13 0.0038
396 HYPOVOLAEMIA 22 0.0038
397 METABOLIC ACIDOSIS 120 0.0037
398 ULCER 59 0.0037
399 NEPHROGENIC ANAEMIA 17 0.0037
400 METABOLIC ENCEPHALOPATHY 11 0.0037
401 SHOCK 84 0.0036
402 SMALL FOR DATES BABY 18 0.0036
403 ENCEPHALOPATHY 89 0.0036
404 BACTERAEMIA 43 0.0036
405 UPPER RESPIRATORY TRACT INFECTION 166 0.0036
406 GASTROOESOPHAGEAL REFLUX DISEASE 289 0.0036
407 ABDOMINAL PAIN UPPER 735 0.0036
408 BRAIN OEDEMA 45 0.0036
409 LABORATORY TEST ABNORMAL 105 0.0036
410 TACHYPNOEA 48 0.0035
411 ENTEROCOCCAL INFECTION 17 0.0035
412 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 250 0.0035
413 DECREASED APPETITE 815 0.0035
414 BLOOD ALKALINE PHOSPHATASE INCREASED 87 0.0035
415 RESPIRATORY TRACT INFECTION 90 0.0035
416 BLOOD PARATHYROID HORMONE INCREASED 10 0.0034
417 DEFORMITY 32 0.0034
418 ANOREXIA 44 0.0034
419 MULTI-ORGAN FAILURE 59 0.0034
420 HEPATITIS 86 0.0034
421 COMPRESSION FRACTURE 18 0.0034
422 DEAFNESS NEUROSENSORY 11 0.0033
423 HYPONATRAEMIA 188 0.0033
424 ADVERSE DRUG REACTION 296 0.0033
425 MUSCULAR WEAKNESS 373 0.0033
426 WEIGHT FLUCTUATION 34 0.0032
427 WEIGHT INCREASED 726 0.0032
428 ADVERSE EVENT 298 0.0032
429 MUCOUS STOOLS 16 0.0032
430 WOUND COMPLICATION 11 0.0032
431 PYREXIA 1109 0.0032
432 URINE OUTPUT DECREASED 28 0.0032
433 POLYURIA 26 0.0032
434 EXTRAVASATION 13 0.0032
435 ACUTE RESPIRATORY DISTRESS SYNDROME 55 0.0031
436 RALES 18 0.0031
437 PARAESTHESIA 487 0.0031
438 HYPERPYREXIA 13 0.0031
439 CYSTIC FIBROSIS 17 0.0031
440 PLATELET COUNT INCREASED 40 0.0031
441 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 23 0.0031
442 NASAL POLYPS 15 0.0030
443 HICCUPS 25 0.0030
444 BODY TEMPERATURE INCREASED 62 0.0030
445 SERUM FERRITIN INCREASED 16 0.0030
446 GLAUCOMA 58 0.0030
447 PNEUMONIA 975 0.0030
448 GOUT 54 0.0030
449 VENTRICULAR ARRHYTHMIA 11 0.0030
450 PROCEDURAL COMPLICATION 23 0.0030
451 LEUKOPENIA 149 0.0030
452 ILEUS 37 0.0030
453 SINUS TACHYCARDIA 42 0.0030
454 CLOSTRIDIAL INFECTION 10 0.0030
455 MUSCLE SPASMS 539 0.0029
456 ASPARTATE AMINOTRANSFERASE INCREASED 156 0.0029
457 PANCREATITIS 155 0.0029
458 HYPOVOLAEMIC SHOCK 14 0.0029
459 FAECALOMA 16 0.0029
460 PRODUCT USE IN UNAPPROVED INDICATION 716 0.0029
461 COAGULOPATHY 48 0.0029
462 EOSINOPHIL COUNT INCREASED 24 0.0029
463 NECROSIS 16 0.0029
464 ABDOMINAL PAIN 668 0.0029
465 VITAMIN D DEFICIENCY 28 0.0029
466 PAIN 1751 0.0028
467 SMALL INTESTINAL OBSTRUCTION 35 0.0028
468 VOMITING 1332 0.0028
469 RESPIRATORY FAILURE 206 0.0028
470 LIMB DISCOMFORT 87 0.0028
471 OBSTRUCTIVE AIRWAYS DISORDER 31 0.0028
472 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12 0.0028
473 COELIAC DISEASE 27 0.0027
474 RASH 1196 0.0027
475 PRE-ECLAMPSIA 13 0.0027
476 SEPSIS 305 0.0027
477 BODY HEIGHT DECREASED 29 0.0027
478 HYPERBILIRUBINAEMIA 28 0.0027
479 TRIGGER FINGER 11 0.0027
480 PROTHROMBIN TIME PROLONGED 16 0.0027
481 GAMMA-GLUTAMYLTRANSFERASE INCREASED 59 0.0027
482 RASH PRURITIC 143 0.0026
483 BLOOD CREATININE INCREASED 172 0.0026
484 PROCEDURAL PAIN 73 0.0026
485 ALANINE AMINOTRANSFERASE INCREASED 161 0.0026
486 MOUTH ULCERATION 55 0.0026
487 LUNG INFILTRATION 23 0.0026
488 INTESTINAL PERFORATION 29 0.0026
489 MULTIPLE MYELOMA 12 0.0026
490 PATHOLOGICAL FRACTURE 13 0.0026
491 ANURIA 22 0.0026
492 BLOOD MAGNESIUM DECREASED 22 0.0025
493 VENTRICULAR TACHYCARDIA 42 0.0025
494 MICTURITION URGENCY 29 0.0025
495 ARTHRALGIA 1052 0.0025
496 BRONCHITIS 184 0.0025
497 ANAEMIA 474 0.0025
498 STILLBIRTH 12 0.0025
499 GAIT DISTURBANCE 468 0.0024
500 MUSCLE SPASTICITY 30 0.0024
501 PAIN IN EXTREMITY 716 0.0024
502 TORSADE DE POINTES 19 0.0024
503 HAEMATOCRIT DECREASED 48 0.0024
504 URINE ABNORMALITY 11 0.0024
505 DISSEMINATED INTRAVASCULAR COAGULATION 34 0.0024
506 PULMONARY OEDEMA 108 0.0024
507 WEIGHT DECREASED 672 0.0024
508 DEVICE RELATED INFECTION 37 0.0024
509 FEELING HOT 147 0.0024
510 TREATMENT NONCOMPLIANCE 131 0.0024
511 BLOOD PRESSURE DIASTOLIC INCREASED 11 0.0024
512 DIVERTICULITIS 66 0.0024
513 INTESTINAL ISCHAEMIA 13 0.0024
514 RESPIRATORY DISTRESS 65 0.0024
515 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 12 0.0023
516 PSORIASIS 305 0.0023
517 ECCHYMOSIS 16 0.0023
518 TACHYCARDIA 207 0.0023
519 PERIPHERAL VASCULAR DISORDER 12 0.0023
520 HYPOTENSION 467 0.0023
521 CYSTITIS 74 0.0023
522 SKIN INFECTION 26 0.0023
523 NEPHROPATHY TOXIC 26 0.0023
524 PULSE ABSENT 11 0.0023
525 MUCOSAL INFLAMMATION 60 0.0023
526 OESOPHAGITIS 25 0.0023
527 CLOSTRIDIUM DIFFICILE COLITIS 24 0.0023
528 GASTROENTERITIS 33 0.0023
529 ASTHENIA 845 0.0022
530 NEUTROPHIL COUNT DECREASED 91 0.0022
531 CYANOSIS 35 0.0022
532 INFLAMMATORY MARKER INCREASED 11 0.0022
533 FATIGUE 1724 0.0022
534 MALAISE 971 0.0022
535 RENAL FAILURE CHRONIC 17 0.0022
536 INTERNATIONAL NORMALISED RATIO INCREASED 63 0.0022
537 BRADYCARDIA 117 0.0022
538 HYPERAMMONAEMIA 11 0.0022
539 DEPRESSION 500 0.0022
540 ABDOMINAL DISTENSION 229 0.0022
541 COLITIS 83 0.0022
542 FEBRILE NEUTROPENIA 144 0.0022
543 HERPES SIMPLEX 14 0.0022
544 BODY TEMPERATURE DECREASED 21 0.0021
545 PNEUMONIA ASPIRATION 53 0.0021
546 ANAL INCONTINENCE 19 0.0021
547 DIABETES MELLITUS 161 0.0021
548 BLOOD PRESSURE SYSTOLIC INCREASED 41 0.0021
549 LEUKOCYTOSIS 38 0.0021
550 UNDERDOSE 153 0.0021
551 HEPATIC STEATOSIS 39 0.0021
552 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
553 HIATUS HERNIA 27 0.0021
554 NYSTAGMUS 11 0.0021
555 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 108 0.0021
556 TRANSAMINASES INCREASED 46 0.0021
557 FINGER DEFORMITY 10 0.0021
558 GRAND MAL CONVULSION 19 0.0021
559 MALNUTRITION 23 0.0021
560 PULMONARY HAEMORRHAGE 16 0.0020
561 DEPRESSED MOOD 108 0.0020
562 IMMUNOSUPPRESSION 18 0.0020
563 HYPERGLYCAEMIA 74 0.0020
564 HAEMODIALYSIS 17 0.0020
565 HAEMOLYTIC ANAEMIA 18 0.0020
566 MULTIPLE FRACTURES 33 0.0020
567 HEPATITIS ACUTE 13 0.0020
568 CARDIAC ARREST 164 0.0020
569 TRANSIENT ISCHAEMIC ATTACK 67 0.0020
570 FULL BLOOD COUNT ABNORMAL 21 0.0020
571 DRUG RESISTANCE 51 0.0020
572 HAEMATURIA 67 0.0020
573 RENAL FAILURE ACUTE 83 0.0020
574 CARDIAC FAILURE ACUTE 13 0.0019
575 UROSEPSIS 18 0.0019
576 MITRAL VALVE INCOMPETENCE 22 0.0019
577 CHOLECYSTITIS ACUTE 11 0.0019
578 DIZZINESS 966 0.0019
579 FAILURE TO THRIVE 10 0.0019
580 DIARRHOEA HAEMORRHAGIC 18 0.0019
581 HYPOGLYCAEMIA 93 0.0019
582 OFF LABEL USE 1670 0.0019
583 DIARRHOEA 1231 0.0019
584 PULMONARY EMBOLISM 181 0.0019
585 ACUTE KIDNEY INJURY 291 0.0019
586 RENAL CYST 15 0.0019
587 INSOMNIA 502 0.0019
588 HYPOTHERMIA 19 0.0019
589 MENTAL STATUS CHANGES 52 0.0019
590 LUNG INFECTION 29 0.0019
591 PRURITUS 716 0.0019
592 HERNIA 36 0.0019
593 BLOOD BILIRUBIN INCREASED 50 0.0018
594 STAPHYLOCOCCAL INFECTION 61 0.0018
595 TOOTH EXTRACTION 23 0.0018
596 NECK PAIN 103 0.0018
597 THROMBOCYTOPENIA 205 0.0018
598 BLOOD LACTATE DEHYDROGENASE INCREASED 29 0.0018
599 DYSPNOEA 1028 0.0018
600 ELECTROCARDIOGRAM QT PROLONGED 65 0.0018
601 NAUSEA 1421 0.0018
602 SPINAL DISORDER 17 0.0018
603 HAEMATOCHEZIA 99 0.0018
604 VISUAL IMPAIRMENT 222 0.0018
605 BREAST MASS 12 0.0018
606 FLUID OVERLOAD 26 0.0018
607 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
608 CIRCULATORY COLLAPSE 30 0.0018
609 ATRIAL FLUTTER 14 0.0018
610 HYDRONEPHROSIS 13 0.0017
611 BASAL CELL CARCINOMA 27 0.0017
612 LACTIC ACIDOSIS 56 0.0017
613 HEADACHE 1084 0.0017
614 INJECTION SITE HAEMORRHAGE 138 0.0017
615 CONJUNCTIVITIS 32 0.0017
616 BONE DENSITY DECREASED 54 0.0017
617 POST PROCEDURAL COMPLICATION 33 0.0017
618 COGNITIVE DISORDER 80 0.0017
619 BONE DISORDER 31 0.0017
620 DRUG INEFFECTIVE 2242 0.0017
621 CONSTIPATION 370 0.0017
622 STATUS EPILEPTICUS 19 0.0017
623 LOW DENSITY LIPOPROTEIN INCREASED 13 0.0017
624 INTENTIONAL OVERDOSE 107 0.0017
625 BLOOD POTASSIUM INCREASED 27 0.0017
626 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
627 PLATELET COUNT DECREASED 176 0.0016
628 INTERVERTEBRAL DISC PROTRUSION 36 0.0016
629 IRON DEFICIENCY ANAEMIA 15 0.0016
630 SPLENOMEGALY 19 0.0016
631 ANXIETY 460 0.0016
632 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
633 ATRIAL FIBRILLATION 156 0.0016
634 NEUROTOXICITY 28 0.0016
635 CHOLECYSTITIS 19 0.0016
636 HEART RATE DECREASED 56 0.0016
637 LOSS OF CONSCIOUSNESS 203 0.0016
638 LARGE INTESTINE PERFORATION 11 0.0016
639 LIVER FUNCTION TEST ABNORMAL 46 0.0016
640 MYOCARDIAL ISCHAEMIA 18 0.0016
641 OSTEOPENIA 24 0.0016
642 SPINAL COMPRESSION FRACTURE 13 0.0016
643 RIGHT VENTRICULAR FAILURE 11 0.0016
644 THYROID DISORDER 24 0.0016
645 TEMPERATURE INTOLERANCE 16 0.0015
646 PERITONITIS 32 0.0015
647 DRUG TOXICITY 21 0.0015
648 BLOOD SODIUM DECREASED 29 0.0015
649 GENERALISED OEDEMA 19 0.0015
650 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
651 PRODUCT QUALITY ISSUE 207 0.0015
652 CHOLESTASIS 29 0.0015
653 BONE PAIN 88 0.0015
654 LACRIMATION INCREASED 45 0.0015
655 BLOOD PRESSURE INCREASED 227 0.0015
656 MUSCLE TWITCHING 34 0.0015
657 HAEMOPTYSIS 41 0.0015
658 SUBDURAL HAEMATOMA 21 0.0015
659 RESPIRATORY RATE INCREASED 13 0.0015
660 BLOOD POTASSIUM DECREASED 44 0.0015
661 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
662 VENTRICULAR EXTRASYSTOLES 15 0.0014
663 CYTOMEGALOVIRUS INFECTION 24 0.0014
664 PULMONARY CONGESTION 19 0.0014
665 INTENTIONAL PRODUCT MISUSE 126 0.0014
666 AUTOIMMUNE HEPATITIS 10 0.0014
667 ATRIOVENTRICULAR BLOCK 11 0.0014
668 CLOSTRIDIUM DIFFICILE INFECTION 31 0.0014
669 PNEUMONIA BACTERIAL 13 0.0014
670 MYELOSUPPRESSION 51 0.0014
671 APNOEA 11 0.0014
672 PSEUDOMONAS INFECTION 12 0.0014
673 EYE DISORDER 46 0.0014
674 WHITE BLOOD CELL COUNT DECREASED 151 0.0014
675 NEPHROPATHY 13 0.0014
676 PULMONARY HYPERTENSION 29 0.0014
677 ACUTE HEPATIC FAILURE 19 0.0014
678 PNEUMOTHORAX 22 0.0014
679 CORONARY ARTERY DISEASE 42 0.0014
680 TRICUSPID VALVE INCOMPETENCE 11 0.0014
681 HAEMOGLOBIN DECREASED 142 0.0014
682 PANCYTOPENIA 77 0.0014
683 SPUTUM DISCOLOURED 13 0.0014
684 THROMBOSIS 110 0.0014
685 CARDIO-RESPIRATORY ARREST 57 0.0014
686 CANDIDA INFECTION 23 0.0014
687 PURPURA 12 0.0014
688 DRUG ERUPTION 24 0.0014
689 HAEMORRHAGE INTRACRANIAL 20 0.0013
690 ACUTE CORONARY SYNDROME 11 0.0013
691 HEPATIC FAILURE 40 0.0013
692 CORONARY ARTERY OCCLUSION 18 0.0013
693 DEHYDRATION 175 0.0013
694 MOVEMENT DISORDER 42 0.0013
695 RASH MACULO-PAPULAR 29 0.0013
696 ANAPHYLACTIC REACTION 72 0.0013
697 GASTRITIS 34 0.0013
698 RENAL FAILURE 171 0.0013
699 SKIN LACERATION 14 0.0013
700 LYMPHOPENIA 18 0.0013
701 RHABDOMYOLYSIS 53 0.0013
702 JAUNDICE 34 0.0013
703 STEVENS-JOHNSON SYNDROME 28 0.0013
704 ACUTE MYOCARDIAL INFARCTION 37 0.0013
705 SPINAL FRACTURE 25 0.0012
706 PETECHIAE 13 0.0012
707 SKIN LESION 34 0.0012
708 MUSCULOSKELETAL CHEST PAIN 19 0.0012
709 DECUBITUS ULCER 10 0.0012
710 INFLAMMATORY BOWEL DISEASE 12 0.0012
711 SOMNOLENCE 246 0.0012
712 OSTEONECROSIS 40 0.0012
713 ESCHERICHIA INFECTION 10 0.0012
714 DEPRESSED LEVEL OF CONSCIOUSNESS 48 0.0012
715 BLOOD PRESSURE DECREASED 80 0.0012
716 HYPOTONIA 12 0.0012
717 VIRAL INFECTION 40 0.0012
718 COMA 57 0.0012
719 HEART RATE INCREASED 118 0.0012
720 CONVULSION 68 0.0012
721 FOETAL EXPOSURE DURING PREGNANCY 96 0.0012
722 PNEUMONITIS 32 0.0012
723 OXYGEN SATURATION DECREASED 66 0.0012
724 PERICARDIAL EFFUSION 27 0.0012
725 MUSCULOSKELETAL DISCOMFORT 20 0.0012
726 OSTEOMYELITIS 21 0.0012
727 APHASIA 35 0.0012
728 CHOLELITHIASIS 38 0.0012
729 RENAL IMPAIRMENT 97 0.0012
730 CHROMATURIA 26 0.0012
731 METASTASES TO LIVER 20 0.0011
732 LYMPHADENOPATHY 40 0.0011
733 PAIN IN JAW 32 0.0011
734 INJECTION SITE DISCOLOURATION 14 0.0011
735 URINARY TRACT INFECTION 191 0.0011
736 CATARACT 66 0.0011
737 FOOT FRACTURE 21 0.0011
738 CEREBRAL INFARCTION 27 0.0011
739 BACK PAIN 256 0.0011
740 ANKLE FRACTURE 17 0.0011
741 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
742 RED BLOOD CELL COUNT DECREASED 31 0.0011
743 CHILLS 127 0.0011
744 HERPES ZOSTER 62 0.0011
745 HYPERTENSIVE CRISIS 12 0.0011
746 ERYTHEMA MULTIFORME 10 0.0011
747 INITIAL INSOMNIA 11 0.0011
748 HEPATIC FUNCTION ABNORMAL 40 0.0011
749 CELLULITIS 54 0.0011
750 FISTULA 12 0.0011
751 IMMUNE SYSTEM DISORDER 14 0.0011
752 UPPER LIMB FRACTURE 21 0.0011
753 RASH ERYTHEMATOUS 50 0.0010
754 INCONTINENCE 11 0.0010
755 LYMPHOMA 16 0.0010
756 RASH MACULAR 36 0.0010
757 DRUG LEVEL INCREASED 17 0.0010
758 NEPHROLITHIASIS 47 0.0010
759 RIB FRACTURE 21 0.0010
760 CARDIOMYOPATHY 15 0.0010
761 DYSARTHRIA 38 0.0010
762 FACE OEDEMA 17 0.0010
763 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
764 FLATULENCE 56 0.0010
765 CARDIOVASCULAR DISORDER 25 0.0010
766 BONE MARROW FAILURE 20 0.0010
767 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54 0.0010
768 JOINT INJURY 21 0.0010
769 HOT FLUSH 74 0.0010
770 METASTASES TO BONE 16 0.0010
771 HEART RATE IRREGULAR 22 0.0010
772 ABASIA 24 0.0010
773 COUGH 272 0.0010
774 THINKING ABNORMAL 18 0.0010
775 FUNGAL INFECTION 32 0.0010
776 DYSPNOEA EXERTIONAL 36 0.0010
777 BLOOD PRESSURE ABNORMAL 19 0.0010
778 PERIPHERAL COLDNESS 13 0.0009
779 CARDIAC FAILURE CONGESTIVE 76 0.0009
780 URINARY INCONTINENCE 28 0.0009
781 FEELING JITTERY 18 0.0009
782 BREAST PAIN 10 0.0009
783 ERUCTATION 18 0.0009
784 MASS 13 0.0009
785 ACCIDENTAL OVERDOSE 34 0.0009
786 URINARY RETENTION 31 0.0009
787 BLOOD IRON DECREASED 11 0.0009
788 NEUTROPENIA 126 0.0009
789 FAECES DISCOLOURED 20 0.0009
790 INJECTION SITE ERYTHEMA 114 0.0009
791 DIALYSIS 13 0.0009
792 ERYTHEMA 188 0.0009
793 BLOOD GLUCOSE INCREASED 172 0.0009
794 LOCALISED INFECTION 22 0.0009
795 ARRHYTHMIA 43 0.0009
796 DEEP VEIN THROMBOSIS 59 0.0009
797 DENTAL CARIES 10 0.0009
798 RESTLESSNESS 33 0.0009
799 MALIGNANT MELANOMA 12 0.0009
800 CARDIOMEGALY 11 0.0009
801 ORAL PAIN 20 0.0009
802 RASH PAPULAR 20 0.0009
803 INJECTION SITE EXTRAVASATION 11 0.0009
804 SKIN ULCER 23 0.0009
805 FEEDING DISORDER 18 0.0009
806 GASTROINTESTINAL HAEMORRHAGE 74 0.0009
807 DERMATITIS ALLERGIC 11 0.0009
808 TREMOR 145 0.0009
809 PULMONARY MASS 13 0.0009
810 PALPITATIONS 101 0.0009
811 CAESAREAN SECTION 10 0.0009
812 DRUG INTERACTION 136 0.0009
813 RETCHING 18 0.0008
814 GALLBLADDER DISORDER 15 0.0008
815 POLLAKIURIA 35 0.0008
816 PARALYSIS 12 0.0008
817 EJECTION FRACTION DECREASED 13 0.0008
818 ACUTE MYELOID LEUKAEMIA 13 0.0008
819 BLOOD GLUCOSE DECREASED 40 0.0008
820 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
821 CHEST DISCOMFORT 85 0.0008
822 EPISTAXIS 62 0.0008
823 TOOTHACHE 15 0.0008
824 PRODUCT PREPARATION ERROR 17 0.0008
825 HEMIPARESIS 14 0.0008
826 HALLUCINATION 62 0.0008
827 KIDNEY INFECTION 16 0.0008
828 PALLOR 22 0.0008
829 DYSGEUSIA 60 0.0008
830 FLUSHING 82 0.0008
831 ORTHOSTATIC HYPOTENSION 14 0.0008
832 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
833 MYALGIA 135 0.0008
834 PRODUCT ADMINISTRATION ERROR 16 0.0008
835 BLOOD URINE PRESENT 15 0.0008
836 PROTEINURIA 15 0.0008
837 HYPERHIDROSIS 101 0.0008
838 SKIN DISCOLOURATION 36 0.0008
839 HYPOTHYROIDISM 25 0.0008
840 VISUAL ACUITY REDUCED 26 0.0008
841 CHRONIC KIDNEY DISEASE 59 0.0008
842 HEPATOCELLULAR INJURY 11 0.0008
843 PRODUCTIVE COUGH 37 0.0008
844 RENAL DISORDER 36 0.0008
845 HAEMATOMA 20 0.0008
846 HAEMORRHAGE 80 0.0008
847 PREMATURE BABY 23 0.0008
848 TOXICITY TO VARIOUS AGENTS 128 0.0008
849 HYPOKINESIA 11 0.0008
850 PANCREATITIS ACUTE 17 0.0008
851 ADVERSE REACTION 10 0.0008
852 PREMATURE DELIVERY 12 0.0008
853 BLOOD PRESSURE FLUCTUATION 18 0.0007
854 EYE HAEMORRHAGE 10 0.0007
855 DYSPHAGIA 71 0.0007
856 LETHARGY 43 0.0007
857 INTESTINAL OBSTRUCTION 28 0.0007
858 BALANCE DISORDER 64 0.0007
859 DYSKINESIA 30 0.0007
860 OVERDOSE 159 0.0007
861 FEELING ABNORMAL 175 0.0007
862 HYPOAESTHESIA ORAL 11 0.0007
863 NEUROPATHY PERIPHERAL 69 0.0007
864 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
865 ANHEDONIA 19 0.0007
866 HOSPITALISATION 111 0.0007
867 DYSSTASIA 21 0.0007
868 SYNCOPE 71 0.0007
869 FEAR 19 0.0007
870 DYSURIA 26 0.0007
871 LIMB INJURY 19 0.0007
872 ANAPHYLACTIC SHOCK 18 0.0007
873 ANGINA PECTORIS 20 0.0007
874 POOR QUALITY SLEEP 15 0.0007
875 RASH GENERALISED 18 0.0007
876 SUICIDE ATTEMPT 42 0.0007
877 SEIZURE 80 0.0007
878 RESPIRATORY ARREST 19 0.0007
879 SENSORY DISTURBANCE 11 0.0007
880 EOSINOPHILIA 12 0.0007
881 GASTRIC ULCER 13 0.0007
882 DYSPHONIA 40 0.0007
883 FEELING COLD 19 0.0007
884 FALL 226 0.0007
885 SWELLING FACE 44 0.0007
886 ABDOMINAL PAIN LOWER 17 0.0007
887 COLON CANCER 10 0.0007
888 HAEMORRHOIDS 13 0.0007
889 HEAD INJURY 21 0.0007
890 EATING DISORDER 14 0.0007
891 AGITATION 48 0.0007
892 CARDIAC FAILURE 52 0.0006
893 PRURITUS GENERALISED 14 0.0006
894 SCAR 11 0.0006
895 CEREBRAL HAEMORRHAGE 23 0.0006
896 INJECTION SITE REACTION 44 0.0006
897 MELAENA 14 0.0006
898 CRYING 23 0.0006
899 THROAT TIGHTNESS 17 0.0006
900 ABSCESS 10 0.0006
901 COLD SWEAT 11 0.0006
902 DRUG EXPOSURE DURING PREGNANCY 21 0.0006
903 DIPLOPIA 16 0.0006
904 THIRST 11 0.0006
905 RENAL INJURY 18 0.0006
906 DISORIENTATION 24 0.0006
907 RESTLESS LEGS SYNDROME 11 0.0006
908 VAGINAL HAEMORRHAGE 26 0.0006
909 DRUG EFFECT DECREASED 32 0.0006
910 AGRANULOCYTOSIS 11 0.0006
911 HAEMATEMESIS 15 0.0006
912 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
913 HYPOPHAGIA 15 0.0006
914 HEPATOTOXICITY 13 0.0006
915 DISEASE PROGRESSION 69 0.0006
916 UNRESPONSIVE TO STIMULI 15 0.0006
917 MUSCULOSKELETAL DISORDER 11 0.0006
918 INFLUENZA LIKE ILLNESS 47 0.0006
919 INJECTION SITE URTICARIA 14 0.0006
920 VISION BLURRED 78 0.0006
921 BLINDNESS 23 0.0006
922 HIP FRACTURE 18 0.0006
923 DRUG WITHDRAWAL SYNDROME 49 0.0006
924 INJECTION SITE RASH 17 0.0006
925 CEREBROVASCULAR ACCIDENT 93 0.0005
926 MULTIPLE SCLEROSIS 26 0.0005
927 VERTIGO 33 0.0005
928 DIABETIC KETOACIDOSIS 13 0.0005
929 SKIN DISORDER 18 0.0005
930 THROAT IRRITATION 24 0.0005
931 BURNING SENSATION 37 0.0005
932 HYPERSOMNIA 15 0.0005
933 TINNITUS 24 0.0005
934 NERVOUSNESS 27 0.0005
935 IRRITABILITY 31 0.0005
936 LUNG NEOPLASM MALIGNANT 21 0.0005
937 UNEVALUABLE EVENT 38 0.0005
938 INTERSTITIAL LUNG DISEASE 24 0.0005
939 INFLUENZA 54 0.0005
940 DISEASE RECURRENCE 23 0.0005
941 NERVOUS SYSTEM DISORDER 15 0.0005
942 INJECTION SITE PRURITUS 32 0.0005
943 NASAL CONGESTION 28 0.0005
944 DEMENTIA 13 0.0005
945 RHINORRHOEA 30 0.0005
946 PLASMA CELL MYELOMA 18 0.0005
947 MENTAL IMPAIRMENT 11 0.0005
948 FEMUR FRACTURE 14 0.0005
949 MYOCARDIAL INFARCTION 78 0.0004
950 OROPHARYNGEAL PAIN 41 0.0004
951 CARDIAC DISORDER 40 0.0004
952 SWOLLEN TONGUE 13 0.0004
953 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 74 0.0004
954 MALIGNANT NEOPLASM PROGRESSION 42 0.0004
955 INJECTION SITE MASS 15 0.0004
956 SKIN EXFOLIATION 34 0.0004
957 NEOPLASM PROGRESSION 14 0.0004
958 SPEECH DISORDER 21 0.0004
959 ABNORMAL DREAMS 11 0.0004
960 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
961 DEATH 330 0.0004
962 MULTIPLE SCLEROSIS RELAPSE 26 0.0004
963 GASTRIC DISORDER 13 0.0004
964 BREAST CANCER FEMALE 10 0.0004
965 DRY EYE 18 0.0004
966 INJECTION SITE PAIN 110 0.0004
967 EYE SWELLING 13 0.0003
968 PROSTATE CANCER 28 0.0003
969 ECZEMA 18 0.0003
970 ANGIOEDEMA 15 0.0003
971 DISTURBANCE IN ATTENTION 18 0.0003
972 PANIC ATTACK 12 0.0003
973 INJECTION SITE SWELLING 25 0.0003
974 COVID-19 56 0.0003
975 INJECTION SITE BRUISING 25 0.0003
976 SUICIDAL IDEATION 27 0.0003
977 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
978 EMOTIONAL DISTRESS 35 0.0003
979 EYE PAIN 16 0.0003
980 BREAST CANCER 26 0.0003
981 HYPOACUSIS 12 0.0003
982 DRY SKIN 37 0.0003
983 SURGERY 15 0.0003
984 NO ADVERSE EVENT 46 0.0003
985 OCULAR HYPERAEMIA 11 0.0002
986 PRODUCT DOSE OMISSION ISSUE 68 0.0002
987 NEOPLASM MALIGNANT 15 0.0002
988 PRODUCT DOSE OMISSION 14 0.0002
989 INCORRECT DOSE ADMINISTERED 44 0.0002
990 EYE IRRITATION 11 0.0002
991 SKIN BURNING SENSATION 12 0.0002
992 DRUG DOSE OMISSION 22 0.0001
993 ACNE 10 0.0001